Unexpected bankruptcies and Blue Owl Capital issues fuel private credit crisis fears as write-offs at UBS and Jefferies surge. Read why a credit crisis is brewing.

Learning how to read stock charts is one of the most essential skills any trader or investor can develop. Stock charts translate raw price and volume data into visual patterns that reveal market ...

Circle Chart (formerly known as Gaon Chart) has revealed its chart rankings for the week of January 25 to 31! WHIB’s first mini album “ROCK THE NATION” debuted at No. 3, while KiiiKiii’s new EP ...

A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...

Bitcoin’s price has plunged into zones historically tagged by long‑term valuation models as “fire sale” levels, according to the latest Bitcoin Rainbow Chart from Bitcoin Magazine Pro. The ...

Circle Chart (formerly known as Gaon Chart) has revealed its chart rankings for the week of January 4 to 10! idntt topped this week’s physical album chart with their new mini album “yesweare,” which ...

Ubisoft in a 2025 corporate press kit has revealed the sales figures and player counts for a number of its franchises. The Tom Clancy's Ghost Recon series with over 40 million units, while Ghost Recon ...

Meta is planning to lay off about 10 percent of staff in its Reality Labs division, which includes the Oculus Studios division that runs first-party game development studios. This is according to The ...

Key abstracts on multiple myeloma from the 2025 American Society of Hematology Annual Meeting are reported by Dr Joseph Mikhael, chief medical officer of the International Myeloma Foundation. Dr ...

Tesla is on track for its worst U.S. sales performance since 2022, and that’s not the only region where the electric-vehicle maker is under pressure. The Austin, Texas-based company is projected to ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...